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Mortality from all cancers combined and major cancers among men and women aged 20 years and over was compared by country of
birth with that of the whole of England and Wales as the reference group. Population data from the 2001 Census and mortality data
for 2001–2003 were used to estimate standardised mortality ratios. Data on approximately 399000 cancer deaths were available,
with at least 400 cancer deaths in each of the smaller populations. Statistically significant differences from the reference group
included: higher mortality from all cancers combined, lung and colorectal cancer among people born in Scotland and Ireland, lower
mortality for all cancers combined, lung, breast and prostate cancer among people born in Bangladesh (except for lung cancer in
men), India, Pakistan or China/Hong Kong, lower lung cancer mortality among people born in West Africa or the West Indies, higher
breast cancer mortality among women born in West Africa and higher prostate cancer mortality among men born in West Africa or
the West Indies. These data may be relevant to causal hypotheses and in relation to health care and cancer prevention.
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Cancer mortality in England and Wales has been shown to vary by
country of birth in analyses performed around three previous
censuses in 1971, 1981 and 1991 (Marmot et al, 1984; Balarajan and
Bulusu, 1990; Wild and McKeigue, 1997; Gill et al, 2002).
Information from these studies is useful for health needs
assessment, policy formulation, health-care delivery and develop-
ment of hypotheses regarding the aetiology of disease (Gill et al,
2002). A review of the available epidemiological data on cancer in
ethnic minority populations up to the mid-1990s concluded that
the most common and preventable cancers among minority ethnic
populations were the same as those for the general population, but
that important differences existed (Bhopal and Rankin, 1996).
Patterns of cancer mortality in recent years may have been affected
by changing patterns of immigration to England and Wales and
increases in the proportion of elderly people in general and
migrant populations.
It is not currently possible to examine mortality by ethnicity in
England and Wales, as country of birth and not ethnicity is
recorded on death certificates. The aim of this analysis was to
provide information on cancer mortality for all cancers combined
and for the four most common causes of cancer death (lung
cancer, female breast cancer, prostate cancer and colorectal
cancer) in England and Wales by country of birth for 2001–
2003. The analysis of relative mortality for childhood cancers and
for less common cancers was beyond the scope of this paper, but
important differences by country of birth have been noted in
previous studies (Swerdlow et al, 1995; Bhopal and Rankin, 1996;
Winter et al, 1999; Cummins et al, 2001).
SUBJECTS AND METHODS
Mortality data
Mortality data for the years 2001–2003 by age, sex, country of
birth and underlying cause of death were obtained for residents of
England and Wales from the Office for National Statistics (ONS).
The analysis was restricted to deaths from 2001 in order to use
data coded according to the International Classification of
Diseases, Tenth Revision (ICD-10) (World Health Organization,
1992) as ICD-9 coding was used until the end of 2000. We included
countries, or groups of countries, if there were over 1000 deaths
from all causes among adults (X20 years of age) born in each
country or group of countries between 2001 and 2003. ICD-10
codes were used as follows: all cancers (C00–C97), lung cancer
(C33–C34), female breast cancer (C50), prostate cancer (C61) and
colorectal cancer (C18–C21).
Population data
Population data by age, sex and country of birth were obtained
from the 2001 Census of England and Wales and are available from
the National Statistics website (www.statistics.gov.uk). Place of
birth was categorised by individual country (Scotland, India,
Bangladesh, Pakistan), the combinations of England and Wales or
the Republic of Ireland and Northern Ireland, or country group
(East Africa, Eastern Europe, Middle East, North Africa, West
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of countries are shown in Table 1.
Statistical analysis
Indirect standardisation was used to adjust for differences in age
distribution between populations of interest using the rates in
England and Wales in 2001 for the whole population by sex and
5-year age group as the standard. Conventional methods were
used to estimate standardised mortality ratios (SMRs) and 95%
confidence intervals (CI) by sex and country of birth for people
aged 20 years and over (Office of Population Censuses and Surveys
and Health and Safety Executive, 1995).
All comparisons in the following text are with mortality in
England and Wales as a whole. We regarded results as statistically
significant if the 95% CI around SMRs did not include 100. Results
are presented in an order defined by geographical groupings.
As people born in England and Wales form a large majority
of the study population, their SMRs tend to be close to
100, indicating little difference from the population as a whole.
However, as a consequence of the large numbers of deaths among
people born in England and Wales, small differences tend to be
statistically significant even when they are unlikely to be clinically
relevant; no further comment is made on the findings for this
group.
RESULTS
Populations studied
The total of the subpopulations included in this study represents
99.5% of the adults aged 20 years or older enumerated in the 2001
Census of England and Wales. Age structures differed between
subpopulations, with individuals born in Bangladesh and West
Africa having a particularly large proportion of people in the
20–44-year age group (data not shown, but available from
www.statistics.gov.uk).
All cancers combined
There were approximately 399000 deaths from cancer in the
populations studied over the period 2001–2003, of which
approximately 365000 were among people born in England and
Wales, 11200 were among people born in Ireland and 9500 were
among people born in Scotland. Standardised mortality ratios for
deaths from all cancers for the adult population (aged 20 and over)
are shown in Figure 1 (Table 2 gives the numbers of deaths and
precise values for CI). Cancer mortality was higher for men and
women born in Scotland or Ireland and men born in West Africa,
but lower for men and women born in East Africa, Bangladesh,
India, Pakistan or China and Hong Kong and for women born in
Table 1 List of countries included in groups of countries of birth
Group Individual countries
East Africa Kenya, Malawi, Tanzania, Uganda, Zambia
Eastern Europe Albania, Belarus, Bosnia and Herzegovinia, Bulgaria, Commonwealth of Russian Independent States nos., Croatia, Czech Republic, Estonia, Hungary,
Latvia, Lithuania, Macedonia, Moldova, Montenegro, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine, Union of Soviet Socialist States
nos. and Yugoslavia
Middle East Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Middle East nos., Occupied Territories (Gaza and West Bank),
Oman, Other Middle East, Qatar, Saudi Arabia, Syrian Arab Republic, United Arab Emirates and Yemen
North Africa Algeria, Canary Islands, Ceuta and Melilla, Cape Verde, Egypt, Libya, Mauritiania, Morocco, North Africa nos., Sudan and Tunisia
West Africa Botswana, Gambia, Ghana, Lesotho, Nigeria, Sierra Leone, Swaziland and Zimbabwe
West Indies Anguilla, Antigua and Barbuda, Bahamas, Barbados, Bermuda, British Virgin Islands, Cayman Islands, Dominica, Gaudeloupe, Grenada, Jamaica,
Martinique, Montserrat, Netherland Antilles, St Christopher (St Kitts) Nevis, St Lucia, St Vincent and the Grenadines, Trinidad and Tobago, Turks and
Caicos Islands, US Virgin Islands, West Indies, West Indies nos.
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Figure 1 Standardised mortality ratios for all cancer deaths by sex and country of birth, England and Wales, 2001–2003.
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population for people born in the Middle East, North Africa, for
men born in Eastern Europe or the West Indies and for women
born in West Africa.
Lung cancer
Lung cancer was the commonest specific cancer represented
among men (c. 51000 deaths). There were approximately 33000
deaths from lung cancer in women, similar to the numbers of
deaths from breast cancer, though for women born in Scotland and
Ireland the numbers were exceeded by lung cancer. Lung cancer
deaths were higher in men than women for all groups, particularly
for people born in Bangladesh, the Middle East and the West
Indies. Lung cancer mortality was high among men and women
born in Scotland and Ireland (see Figure 2 and Table 3), but
similar to the reference group among men and women born in
North Africa, or men born in Bangladesh, Eastern Europe and the
Middle East. For people born in the other countries studied, lung
cancer mortality was low.
Female breast cancer
The overall numbers of deaths among women from breast cancer
(33291) across the study period were similar to those from lung
cancer (33311). For most subgroups by country of birth, with
the exception of Scotland and Ireland as mentioned above, the
numbers of deaths from breast cancer were either similar
(for women born in England and Wales, Eastern Europe or
Bangladesh) or exceeded those for lung cancer among women.
Table 2 Numbers of deaths and all cancer (ICD-10 C00–C97) SMRs by
sex and country of birth for people aged 20 years and above
Men Women
No. of
deaths
SMR (95%
CI)
No. of
deaths
SMR (95%
CI)
England and Wales 188495 98 (97–98) 175976 97 (97–98)
Scotland 5271 115 (111–118) 4372 112 (109–115)
Ireland 6110 125 (122–129) 5130 110 (107–113)
Eastern Europe 1979 95 (91–100) 878 93 (87–99)
East Africa 384 75 (67–83) 361 84 (75–93)
North Africa 206 93 (81–108) 197 107 (92–104)
West Africa 352 115 (103–128) 280 109 (97–124)
Middle East 685 100 (93–109) 447 93 (84–102)
Bangladesh 283 85 (75–96) 117 65 (53–79)
India 1440 58 (55–61) 1410 72 (68–76)
Pakistan 526 60 (55–66) 414 69 (62–76)
West Indies 1679 103 (98–108) 996 82 (77–88)
China and Hong
Kong
287 84 (74–94) 240 81 (71–93)
CI¼confidence interval; ICD¼International Classification of Diseases; SMR¼
standardised mortality ratio.
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Figure 2 Standardised mortality ratios for lung cancer deaths by sex and country of birth, England and Wales, 2001–2003.
Table 3 Numbers of deaths and lung cancer (ICD-10 C33–C34) SMRs
by sex and country of birth for people 20+ years of age
Men Women
No. of
deaths
SMR (95%
CI)
No. of
deaths
SMR (95%
CI)
England and Wales 46280 97 (97–98) 30710 98 (97–99)
Scotland 1506 132 (125–139) 1026 147 (138–157)
Ireland 1848 149 (143–157) 1167 136 (128–144)
Eastern Europe 497 98 (90–108) 118 70 (57–84)
East Africa 61 48 (37–62) 22 31 (19–46)
North Africa 43 79 (58–107) 26 79 (51–115)
West Africa 50 68 (50–89) 16 40 (23–65)
Middle East 148 87 (74–103) 30 35 (23–50)
Bangladesh 99 116 (94–141) 11 36 (18–65)
India 279 44 (39–50) 158 45 (38–53)
Pakistan 128 58 (48–70) 32 31 (21–43)
West Indies 348 81 (73–91) 51 22 (17–29)
China and Hong
Kong
63 74 (57–95) 34 67 (47–94)
CI¼confidence interval; ICD¼International Classification of Diseases; SMR¼
standardised mortality ratio.
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North and West Africa, though the difference was only significant
among the latter (see Figure 3 and Table 4). Low SMRs were found
in women born in Eastern Europe, Bangladesh, India, Pakistan,
China and Hong Kong.
Prostate cancer
Mortality from prostate cancer (c. 27000) was approximately two
to three times higher for men born in West Africa and the West
Indies (see Figure 4 and Table 5), but low for men born in Eastern
Europe, the Middle East, Bangladesh, India, Pakistan, China and
Hong Kong.
Colorectal cancer
There were approximately 22000 colorectal cancer deaths among
men and approximately 20000 among women; mortality was
higher than the national average in men and women born in
Scotland, and men born in Ireland (see Figure 5 and Table 6).
However, for men and women born in Bangladesh, India and
Pakistan, men born in East Africa, the Middle East and the West
Indies, and women born in China and Hong Kong, SMRs were
significantly lower than for England and Wales as a whole.
DISCUSSION
This analysis has extended previous work (Wild and McKeigue,
1997) by including a wider range of countries of birth and
extending the types of cancer studied, and has shown important
differences in cancer mortality by country of birth. A complex
combination of genetic and environmental factors, including diet,
lifestyle and socio-economic status, contributes to differences in
cancer incidence and mortality between populations and is not
considered further in this descriptive paper. Migrant studies can be
useful in separating the role of genetic and environmental factors
(Parkin, 2004). Longer duration of residence in the UK is associated
with increased mortality from cancer among South Asians and this
may be related to changes in diet and lifestyle (Harding, 2003).
Country of birth is not a reliable measure of ethnicity because,
for example, a large proportion of people born in East Africa who
live in England and Wales are of South Asian ethnicity (see
Table S102 of the 2001 Census for England and Wales, available
from www.statistics.gov.uk). Further research is required
to establish patterns of cancer mortality among offspring of
migrants.
Mortality is a function of incidence and survival, and mortality
differences may reflect differences in either or both of these
factors. In a study of 356555 cancer cases (ICD-9 140–208)
registered between 1990 and 1992 with the Thames, Trent, West
Midlands and Yorkshire cancer registries, incidence rates for all
cancer sites combined were significantly lower among South
Asians than non-South Asians (Winter et al, 1999). Data from the
Longitudinal Study, based on a 1% sample of the population of
England and Wales, have been used to compare cancer incidence
among first-generation Scottish, Irish, West Indian and South
Asian migrants living in England and Wales (Harding and Rosato,
1999). The high cancer incidence among people born in Scotland
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Figure 3 Standardised mortality ratios for female breast cancer deaths by country of birth, England and Wales, 2001–2003.
Table 4 Numbers of deaths and breast cancer (ICD-10 C50) SMRs
among women of 20+ years of age by country of birth
No. of deaths SMR (95% CI)
England and Wales 30759 98 (97–99)
Scotland 700 102 (94–110)
Ireland 736 93 (86–100)
Eastern Europe 126 81 (67–97)
East Africa 101 99 (80–122)
North Africa 45 132 (96–176)
West Africa 83 132 (105–163)
Middle East 102 108 (88–133)
Bangladesh 11 27 (14–49)
India 284 79 (70–89)
Pakistan 91 73 (58–91)
West Indies 208 92 (80–106)
China and Hong Kong 45 77 (56–103)
CI¼confidence interval; ICD¼International Classification of Diseases; SMR¼
standardised mortality ratio.
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West Indies or South Asia is similar to the patterns we have
reported for mortality (Harding and Rosato, 1999).
Lung cancer mortality largely reflects smoking habits of
populations 20–30 years previously and the higher level in
migrants from Scotland and Ireland to England and Wales
supports previous findings (Wild and McKeigue, 1997; Harding
and Rosato, 1999). Although lung cancer mortality is lower among
South Asian populations (other than men born in Bangladesh)
than the general population of England and Wales, lung cancer is
the commonest cancer among South Asian men, among whom
incidence is increasing (Smith et al, 2003).
The high breast cancer mortality among women born in North
and West Africa (which was only statistically significant in the
latter) was unexpected. A nonsignificantly elevated SMR in the
1991 Census for breast cancer among women born in West Africa
is unexplained (SMR 125, 95% CI 91–168) (Wild and McKeigue,
1997). A French study that adjusted for confounding factors such
as social class and area of residence did not find an excess of breast
cancer mortality in migrants from sub-Saharan Africa compared to
French natives (Bouchardy et al, 1995).
Lower incidence of breast cancer has previously been reported
for women born in South Asia and the West Indies (Harding and
Rosato, 1999). A national study reported substantially lower breast
cancer incidence in South Asians than other women in England
and Wales, and found evidence that South Asian women had better
breast cancer survival than other women in England and Wales,
both overall and in each deprivation category, at least for
diagnoses prior to 1990 (Farooq and Coleman, 2005). Better
survival in breast cancer among South Asian than in other women
in South East England is apparently not explained by differences in
age at diagnosis, socioeconomic deprivation or disease stage at
presentation (dos Santos Silva et al, 2003). However, survival was
similar in South Asian and non-Asian women in West Yorkshire,
although the former presented later to their GPs, with larger
primary tumours, and more frequently underwent mastectomy
(Velikova et al, 2004).
We found increased mortality from prostate cancer among men
born in West Africa or the West Indies, consistent with incidence data
which reported a doubling of the two-fold standardised incidence
ratios for West Indian men from the Longitudinal Study, compared
with all men (2.2, 95% CI 1.0–4.1) (Harding and Rosato, 1999).
Marked differences in the incidence of colorectal cancer have
been recorded across the world with the highest rates in North
America, Australia and New Zealand and Western and Eastern
Europe, and low rates in Africa and Asia (Parkin, 2004). Incidence
of colorectal cancer appears to increase rapidly in the first
generation of migrants from low- to high-risk areas, suggesting an
important aetiological role for environmental factors, particularly
diet (McMichael et al, 1980). A strong relationship between
colorectal cancer and diet is also suggested by the results of
ecological studies, which indicate associations between colorectal
cancer incidence and intake of meat and fat (Armstrong and Doll,
1975; Prentice and Sheppard, 1990).
Potential sources of bias in these estimates, including errors in
population estimates, return migration, numerator–denominator
bias (e.g. when country of birth for an individual is recorded
differently in the Census and on a death certificate), and inaccurate
reporting of cause of death, were previously considered in more
Men
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Figure 4 Standardised mortality ratios for prostate cancer deaths by country of birth, England and Wales, 2001–2003.
Table 5 Numbers of deaths and prostate cancer (ICD-10 C61) SMRs
among men of 20+ years of age by country of birth
No. of deaths SMR (95% CI)
England & Wales 24322 98 (97–99)
Scotland 579 101 (93–110)
Ireland 638 106 (98–115)
Eastern Europe 247 76 (67–87)
East Africa 31 85 (58–121)
North Africa 20 90 (55–139)
West Africa 60 271 (207–349)
Middle East 53 75 (57–99)
Bangladesh 6 21 (8–45)
India 183 64 (55–75)
Pakistan 61 72 (55–93)
West Indies 350 198 (178–221)
China and Hong Kong 20 55 (34–85)
CI¼confidence interval; ICD¼International Classification of Diseases; SMR¼
standardised mortality ratio.
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cause of death described on death certificates by country of birth.
Under-enumeration in the Census is more marked among some
subgroups of the population, such as young men living in inner
cities, and this may be even more marked for some further
population subgroups. A study in London suggested that current
population numbers of older people are underestimated (and
therefore SMRs are overestimated), with a particularly marked
effect among people born in East Africa, Scotland or Ireland
(Bardsley et al, 2000).
The issue of misclassification of country of birth among older
people who were born in parts of what was previously India that
are now Bangladesh or Pakistan does not appear to be a major
problem, as mortality ratios for different conditions (e.g. cancer
and cardiovascular disease) for people born in India, Pakistan or
Bangladesh are not consistently elevated or reduced. Only data for
Ireland as a whole could be considered because of the difficulty of
separating data for people born in Northern Ireland and the
Republic.
The poor uptake of cancer screening among ethnic minorities
may mean that cancer mortality in these groups could be reduced
if the use of these services could be improved (Caine et al, 2001).
Data regarding the use of health services among people with cancer
from different ethnic groups are limited. A study of the relation-
ship between socio-demographic factors and the components of
diagnostic delay (total, patient and primary care, referral and
secondary care) for six cancers (breast, colorectal, lung, ovarian,
prostate and non-Hodgkin’s lymphoma) found that there was
greater diagnostic delay for breast cancer for black and South
Asian groups (Neal and Allgar, 2005).
CONCLUSION
The above variations in cancer mortality, which are unlikely to be
due to data artefact, may be relevant to causal hypotheses and in
relation to health care and cancer prevention.
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